AdvanSix (NYSE:ASIX) Reaches New 12-Month Low at $21.47

Shares of AdvanSix Inc. (NYSE:ASIX) reached a new 52-week low during trading on Friday . The stock traded as low as $21.47 and last traded at $21.47, with a volume of 7479 shares changing hands. The stock had previously closed at $22.15.

Analysts Set New Price Targets

Separately, Stifel Nicolaus reissued a “buy” rating and set a $40.00 price target on shares of AdvanSix in a research report on Tuesday, April 9th.

AdvanSix Stock Down 2.5 %

The stock has a market capitalization of $579.02 million, a PE ratio of 738.33 and a beta of 1.70. The company has a current ratio of 1.38, a quick ratio of 0.71 and a debt-to-equity ratio of 0.34. The company’s 50-day moving average is $23.69 and its 200 day moving average is $26.07.

AdvanSix (NYSE:ASIX) last announced its quarterly earnings data on Friday, May 3rd. The company reported ($0.63) EPS for the quarter, missing the consensus estimate of ($0.61) by ($0.02). The company had revenue of $336.83 million during the quarter, compared to analysts’ expectations of $344.63 million. AdvanSix had a net margin of 0.15% and a return on equity of 0.06%. As a group, analysts anticipate that AdvanSix Inc. will post 1.22 EPS for the current year.

AdvanSix Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Tuesday, May 28th. Investors of record on Tuesday, May 14th were issued a $0.16 dividend. The ex-dividend date of this dividend was Monday, May 13th. This represents a $0.64 annualized dividend and a yield of 2.96%. AdvanSix’s dividend payout ratio (DPR) is presently 2,133.33%.

Insider Buying and Selling

In related news, SVP Achilles B. Kintiroglou sold 3,661 shares of the stock in a transaction that occurred on Wednesday, May 1st. The shares were sold at an average price of $25.23, for a total value of $92,367.03. Following the transaction, the senior vice president now owns 35,335 shares in the company, valued at approximately $891,502.05. The sale was disclosed in a filing with the SEC, which is available through this link. 5.60% of the stock is owned by corporate insiders.

Institutional Investors Weigh In On AdvanSix

A number of hedge funds and other institutional investors have recently made changes to their positions in the company. Boston Partners acquired a new stake in shares of AdvanSix during the 1st quarter worth approximately $702,000. EMC Capital Management acquired a new stake in AdvanSix in the 1st quarter valued at $271,000. Comerica Bank grew its stake in AdvanSix by 48.9% in the 1st quarter. Comerica Bank now owns 19,385 shares of the company’s stock valued at $554,000 after acquiring an additional 6,362 shares during the period. Price T Rowe Associates Inc. MD acquired a new stake in AdvanSix in the 1st quarter valued at $215,000. Finally, CANADA LIFE ASSURANCE Co grew its stake in AdvanSix by 8.5% in the 1st quarter. CANADA LIFE ASSURANCE Co now owns 24,305 shares of the company’s stock valued at $694,000 after acquiring an additional 1,904 shares during the period. Institutional investors and hedge funds own 86.39% of the company’s stock.

About AdvanSix

AdvanSix Inc engages in the manufacture and sale of polymer resins in the United States and internationally. It offers Nylon 6, a polymer resin, which is a synthetic material used to produce fibers, filaments, engineered plastics, and films. The company also provides caprolactam to manufacture polymer resins; ammonium sulfate fertilizers to distributors, farm cooperatives, and retailers; and acetone that are used in the production of adhesives, paints, coatings, solvents, herbicides, and engineered plastic resins, as well as other intermediate chemicals, including phenol, monoisopropylamine, dipropylamine, monoallylamine, alpha-methylstyrene, cyclohexanone, methyl ethyl ketoxime, acetaldehyde oxime, 2-pentanone oxime, cyclohexanol, sulfuric acid, ammonia, and carbon dioxide.